Dementia-Information-Page

Dementia Information Page


What research is being done?

Several ongoing clinical studies are helping researchers better understand the dementias and find better ways to safely detect, treat, or prevent dementias. A number of drugs and compounds that might slow the progression of Alzheimer’s disease and other dementias are in various stages of testing. NIH scientists continue to look for new genes that may be responsible for the development of Alzheimer’s disease and other forms of dementia. Several research projects hope to identify dementia biomarkers (measurable biological signs that may indicate disease risk and progression or confirm diagnosis). Scientists are also studying groups of people over time in hopes of finding ways to identify those at risk of developing dementia or cognitive impairment.

Information from the National Library of Medicine’s MedlinePlus
Dementia

×
What research is being done?

Several ongoing clinical studies are helping researchers better understand the dementias and find better ways to safely detect, treat, or prevent dementias. A number of drugs and compounds that might slow the progression of Alzheimer’s disease and other dementias are in various stages of testing. NIH scientists continue to look for new genes that may be responsible for the development of Alzheimer’s disease and other forms of dementia. Several research projects hope to identify dementia biomarkers (measurable biological signs that may indicate disease risk and progression or confirm diagnosis). Scientists are also studying groups of people over time in hopes of finding ways to identify those at risk of developing dementia or cognitive impairment.

Information from the National Library of Medicine’s MedlinePlus
Dementia

Several ongoing clinical studies are helping researchers better understand the dementias and find better ways to safely detect, treat, or prevent dementias. A number of drugs and compounds that might slow the progression of Alzheimer’s disease and other dementias are in various stages of testing. NIH scientists continue to look for new genes that may be responsible for the development of Alzheimer’s disease and other forms of dementia. Several research projects hope to identify dementia biomarkers (measurable biological signs that may indicate disease risk and progression or confirm diagnosis). Scientists are also studying groups of people over time in hopes of finding ways to identify those at risk of developing dementia or cognitive impairment.

Information from the National Library of Medicine’s MedlinePlus
Dementia


Definition
Definition
Treatment
Treatment
Prognosis
Prognosis
Clinical Trials
Clinical Trials
Organizations
Organizations
Publications
Publications
225 North Michigan Avenue.
Floor 17
Chicago, IL 60601-7633
Tel: 312-335-8700; 800-272-3900 (24-Hour Helpline); 312-335-5886 (TDD)
National Institute on Aging
P.O. Box 8250
Silver Spring, MD 20907-8250
Tel: 1-800-438-4380
322 Eighth Avenue
7th Floor
New York, NY 10001
Tel: 866-AFA-8484 (232-8484)
57 West 57th Street
Suite 904
New York, NY 10019
Tel: 212-901-8000
22512 Gateway Center Drive
Clarksburg, MD 20871
Tel: 1- 800-437-2423
11620 Wilshire Blvd.
Suite 270
Los Angeles, CA 90025
Tel: 310-445-4650
912 Killian Hill Road, S.W.
Lilburn, GA 30047
Tel: 404-935-6444; 800-539-9767
National Institutes of Health, DHHS
6001 Executive Blvd. Rm. 8184, MSC 9663
Bethesda, MD 20892-9663
Tel: 301-443-4513; 866-615-6464; 866-415-8051 (TTY)
55 Kenosia Avenue
Danbury, CT 06810
Tel: 203-744-0100; Voice Mail: 800-999-NORD (6673)